White House Announces Soybean and Rare Earth Deals After TrumpXi Summit China Signals Potential Tariff Reductions
Treasury Yields Edge Lower as Iran Peace Deal Optimism Tempers Geopolitical Concerns
Rachel Reeves Launches Bid to Remain UK Chancellor Amid Potential Labour Leadership Change
Tennis Stars Limit Media Duties at French Open in Prize Money Protest
EUs Attached Bottle Cap Regulation A Case Study in Regulatory Value and Market Impact
Foreign Investors Rotate from Nifty Giants to Indias Small and Midcap Markets Amid Growth Opportunities
AEON Q4 2025 Earnings EPS Misses Estimates by Wide Margin Amid PreRevenue Stage
Citizens Financial Group CFG Q1 2026 Earnings EPS Beat by 281 Amid Steady Performance
ATCH Q1 2026 Earnings NarrowerThanExpected Loss but Stock Declines on Revenue Disappointment
YOU Q1 2026 Earnings EPS Beats Estimates by 12 but Stock Declines Despite Profit Surprise
CPS Technologies Corp CPSH Q1 2026 Earnings EPS Misses Estimates as Stock Gains on Positive Momentum
TTGT Q1 2026 Earnings Significant EPS Miss Amidst Challenging Transition
Fidelis Insurance Holdings FIHL Slips Slightly Testing Support Levels
SuperX AI Surges 119 Is Momentum Building for SUPX Stock
Gorilla Technology Warrant GRRRW Retreats Toward Support Amid Thin Trading
Nuveen Select Maturities Municipal Fund NIM Holds Steady at 928 as Consolidation Persists
Structure Therapeutics GPCR Shows Modest Gains as Biotech Sentiment Improves
Loar Holdings LOAR Advances Modestly as Stock Nears Midpoint of Recent Range
First Citizens BancShares FCNCA Holds Near 2000 as Modest Gains Signal Cautious Optimism
abrdn National Municipal Income Fund VFL Edges Higher as Price Nears Resistance
Textron Inc TXT Edges Higher Amid Defense Sector Strength
Li Bang International LBGJ Posts Modest Gain Holds Above Key 085 Support
Perimeter Solutions SA PRM Edges Higher on Modest Gains as Shares Test Key Moving Averages
Shiruko Sand Maker Expands to Singapore and Southeast Asia
Alto Ingredients Inc ALTO Q1 2026 Earnings Surprise Profit on Strong Cost Management and Improved Margins
Bolt Biotherapeutics BOLT Gains 36 as Biotech Sector Shows Renewed Interest